231 related articles for article (PubMed ID: 17918125)
1. Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
Presterl E; Lassnigg A; Eder M; Reichmann S; Hirschl AM; Graninger W
Int J Artif Organs; 2007 Sep; 30(9):798-804. PubMed ID: 17918125
[TBL] [Abstract][Full Text] [Related]
2. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
[TBL] [Abstract][Full Text] [Related]
3. Infective endocarditis treated with linezolid: case report and literature review.
Hill EE; Herijgers P; Herregods MC; Peetermans WE
Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):202-4. PubMed ID: 16525776
[No Abstract] [Full Text] [Related]
4. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
[TBL] [Abstract][Full Text] [Related]
5. ANTI-ADHESIVE AND ANTI-BIOFILM ACTIVITIES IN VITRO OF LINEZOLID, VANCOMYCIN, TIGECYCLINE AND DAPTOMYCIN AGAINST STAPHYLOCOCCUS HAEMOLYTICUS.
Juda M; Helon P; Malm A
Acta Pol Pharm; 2016 Nov; 73(6):1539-1543. PubMed ID: 29634108
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
[TBL] [Abstract][Full Text] [Related]
7. Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
Hajdu S; Lassnigg A; Graninger W; Hirschl AM; Presterl E
J Orthop Res; 2009 Oct; 27(10):1361-5. PubMed ID: 19396814
[TBL] [Abstract][Full Text] [Related]
8. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
[TBL] [Abstract][Full Text] [Related]
9. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
10. Treatment of vancomycin-intermediate Staphylcoccus aureus endocarditis with linezolid.
Leung KT; Tong MK; Siu YP; Lam CS; Ng HL; Lee HK
Scand J Infect Dis; 2004; 36(6-7):483-5. PubMed ID: 15307573
[TBL] [Abstract][Full Text] [Related]
11. Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
Jenkins I
J Hosp Med; 2007 Sep; 2(5):343-4. PubMed ID: 17935250
[No Abstract] [Full Text] [Related]
12. Inhibition of biofilm maturation by linezolid in meticillin-resistant Staphylococcus epidermidis clinical isolates: comparison with other drugs.
Reiter KC; Villa B; Paim TGDS; de Oliveira CF; d'Azevedo PA
J Med Microbiol; 2013 Mar; 62(Pt 3):394-399. PubMed ID: 23161766
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of the antimicrobial resistance of biofilms].
Soriano A
Enferm Infecc Microbiol Clin; 2007; 25(7):423-4. PubMed ID: 17692208
[No Abstract] [Full Text] [Related]
14. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
Raad I; Hanna H; Jiang Y; Dvorak T; Reitzel R; Chaiban G; Sherertz R; Hachem R
Antimicrob Agents Chemother; 2007 May; 51(5):1656-60. PubMed ID: 17353249
[TBL] [Abstract][Full Text] [Related]
15. Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010.
Tsai HY; Liao CH; Chen YH; Lu PL; Huang CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
Antimicrob Agents Chemother; 2012 Jun; 56(6):3402-5. PubMed ID: 22491684
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Dailey CF; Dileto-Fang CL; Buchanan LV; Oramas-Shirey MP; Batts DH; Ford CW; Gibson JK
Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
[TBL] [Abstract][Full Text] [Related]
17. Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009.
Dowzicky MJ; Chmelařová E
Int J Antimicrob Agents; 2011 Jun; 37(6):562-6. PubMed ID: 21497066
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility against penicillin, ampicillin and vancomycin of viridans group Streptococcus in oral microbiota of patients at risk of infective endocarditis.
Süzük S; Kaşkatepe B; Çetin M
Infez Med; 2016 Sep; 24(3):190-3. PubMed ID: 27668898
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].
Pelitli TS; Cesur S; Kınıklı S; Irmak H; Demiröz AP; Karakoç E
Mikrobiyol Bul; 2011 Oct; 45(4):758-61. PubMed ID: 22090309
[TBL] [Abstract][Full Text] [Related]
20. Early switch from vancomycin to oral linezolid for treatment of gram-positive heart valve endocarditis.
Colli A; Campodonico R; Gherli T
Ann Thorac Surg; 2007 Jul; 84(1):87-91. PubMed ID: 17588391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
